Please Wait
Applying Filters...
menu
    • menu
    IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    EIDD 2801

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 422Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Wedgewood Pharmacy Adds GS-441524 to Its FIP Treatment Portfolio
    Wedgewood Pharmacy Adds GS-441524 to Its FIP Treatment Portfolio

    05 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250605659867/en/Wedgewood-Pharmacy-Adds-GS-441524-to-Its-FIP-Treatment-Portfolio

    BUSINESSWIRE
    05 Jun 2025
    Share Share
    Merck & Ridgeback Start Ph 3 Study of LAGEVRIO™ for COVID-19
    Merck & Ridgeback Start Ph 3 Study of LAGEVRIO™ for COVID-19

    05 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241205097781/en

    BUSINESSWIRE
    05 Dec 2024
    Share Share
    Wedgewood Launches Molnupiravir for FIP Treatment
    Wedgewood Launches Molnupiravir for FIP Treatment

    18 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240918481321/en

    BUSINESSWIRE
    18 Sep 2024
    Share Share
    With $640M in sales of Lagevrio, Merck bumps up revenue forecast
    With $640M in sales of Lagevrio, Merck bumps up revenue forecast

    26 Oct 2023

    // Kevin Dunleavy FIERCE PHARMA

    https://www.fiercepharma.com/pharma/merck-raises-revenue-guidance-thanks-surprising-bump-covid-19-pill-lagevrio

    Kevin Dunleavy FIERCE PHARMA
    26 Oct 2023
    Share Share
    Merck's Lagevrio to be sold commercially in November, HHS says
    Merck's Lagevrio to be sold commercially in November, HHS says

    05 Oct 2023

    // Zoey Becker FIERCE PHARMA

    https://www.fiercepharma.com/pharma/mercks-lagevrio-hit-commercial-market-november-hhs-says

    Zoey Becker FIERCE PHARMA
    05 Oct 2023
    Share Share
    Merck's Lagevrio may have triggered new COVID variants: study
    Merck's Lagevrio may have triggered new COVID variants: study

    26 Sep 2023

    // Kevin Dunleavy FIERCE PHARMA

    https://www.fiercepharma.com/pharma/has-mercks-lagevrio-fueled-evolution-covid-variants-researchers-say-its-possible

    Kevin Dunleavy FIERCE PHARMA
    26 Sep 2023
    Share Share